Antidepressant medicine use in Canada has shown a general upward trend over the past decade. In 2023, the use stood at 139.6 Defined Daily Dosage Per Thousand Persons Per Day. Year-on-year variations in use reflect both incremental growth and occasional spikes, such as the notable 11.1% jump in 2016. The average annual growth rate (CAGR) over the last five years stood at approximately 5.19%, indicating consistent increases in usage.
From 2022 to 2023, usage saw an increase of 4.18%, while the previous year witnessed a 3% rise. Forecasted data suggests a continued upward trajectory, with an estimated 2.87% CAGR from 2023 to 2028, culminating in a 15.22% growth rate over the next five years.
Future trends to watch for:
- Potential shifts in healthcare policies impacting medication accessibility.
- Advancements in alternative mental health treatments.
- Public health initiatives aimed at addressing the root causes of depression.
- Changes in societal attitudes toward mental health care and medication usage.
